文献速递神经肿瘤

三维全脑代谢物成像提升低至中级别胶质瘤表征

3D whole-brain metabolite imaging to improve characterization of low-to-intermediate grade gliomas.
PubMed 文献 · J Neurooncol · 2021-05-13

中位随访27.3个月,5例复发,复发区域与诊断时MRSI代谢异常区域重叠。结论认为MRSI可预测低至中级别胶质瘤后续复发区域,但需更大研究验证其指导手术和放疗计划的价值。

要点

  • MRSI代谢异常区域可预测低至中级别胶质瘤的复发位置。
  • Cho/NAA图可整合入立体定向活检软件辅助组织取样。
  • 常规MRI对低至中级别胶质瘤强化不明显,MRSI可补充表征。

核心结论

  • MRSI在低至中级别胶质瘤患者中可预测后续复发区域。
  • 需更大研究确定MRSI能否指导手术和放疗计划。

研究设计与样本

  • 前瞻性纳入II级和III级胶质瘤患者,组织取样前接受全脑高分辨率MRSI。

主要发现

  • 5例患者出现复发,复发区域与诊断时MRSI代谢异常区域重叠。
  • Cho/NAA图叠加于解剖影像并导入立体定向活检软件。

临床怎么用

  • 可考虑将MRSI代谢异常区域作为活检和放疗靶区参考。
  • 目前证据尚不足以常规用于指导手术和放疗计划。

局限性

  • 结论主要基于复发区域与代谢异常区域的重叠观察。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: MRI is the standard imaging modality used for diagnosis, treatment planning, and post-treatment management of gliomas. Contrast-enhanced T1-weighted (CE-T1w) MRI is used to plan biopsy and radiation for grade IV gliomas but is less effective for grade II and III gliomas (i.e., low-to-intermediate grade gliomas) which may have minimal or no enhancement. Magnetic resonance spectroscopic imaging (MRSI) is an advanced MRI technique that has been shown, to improve diagnostic yield of biopsy and target delineation for grade IV glioma. The purpose of this study is to determine if MRSI can improve characterization and tissue sampling of low-to-intermediate grade gliomas. METHODS: Prospective grade II and grade III glioma patients were enrolled to undergo whole brain high-resolution MRSI prior to tissue sampling. Choline/N-acetyl-aspartate (Cho/NAA) maps were overlaid on anatomic imaging and imported into stereotactic biopsy software. Patients were treated with standard-of-care surgery and radiation. Volumes of spectroscopically abnormal tissue were generated and compared with anatomic imaging and areas of enhancing recurrence on follow-up imaging. RESULTS: Ten patients had pathologic diagnosis of grade II (n = 4) or grade III (n = 6) with a median follow-up of 27.3 months. Five patients had recurrence, and regions of recurrence were found to overlap with metabolically abnormal regions on MRSI at the time of diagnosis. CONCLUSION: MRSI in low-to-intermediate grade glioma patients is predictive of areas of subsequent recurrence. Larger studies are needed to determine if MRSI can be used to guide surgical and radiation treatment planning in these patients.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Zhong J, Huang V, Gurbani SS, et al. 3D whole-brain metabolite imaging to improve characterization of low-to-intermediate grade gliomas. J Neurooncol. 2021. PMID: 33983570. doi:10.1007/s11060-021-03770-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。